2025 · 4th Quarter (Oct 1 - Dec 31)

ORGANOGENESIS INC.

Filed by ARENTFOX SCHIFF LLP.

Open official filing

Source-reported fields

Filing overview

Type: 4th Quarter - Report
Posted: Jan 20, 2026
Income: $70,000.00
Expenses: Not reported
Registrant: ARENTFOX SCHIFF LLP
Client: ORGANOGENESIS INC.
Filing UUID: 36b641a0-fc8e-40c0-bd8a-5065b68be3cc
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R. 5304 and S. 2587 (Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, 2026), regarding reimbursement for chronic wound healing products

Literal federal measure citations: H.R. 5768, S. 2561, H.R. 5304, S. 2587

HCR · Health Issues

Food and Drug Administration policy on chronic wound healing products

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.